Special Sessions
| SS 4. PSA R&D: What is needed? | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Date | Oct. 5 (Wed) | ||||||||||||
| Time | 10:30-12:30 | ||||||||||||
| Venue | Vista Hall (B2) | ||||||||||||
| Organizers |
Nathan SIU (U.S. Nuclear Regulatory Commission, United States) Jiejuan TONG (Tsinghua University, China) Enrico ZIO (CentraleSupelec and Politecnico Di Milano, Italy) |
||||||||||||
| Overview | |||||||||||||
| Although most members of the Probabilistic Safety Assessment (PSA) community would probably agree that PSA research and development (R&D) is a necessary activity in a risk-informed decisionmaking environment, perspectives on what R&D is needed can dier. Dierent experts can have dierent ideas as to what issues are important, which ones merit R&D, what R&D should be performed, and how the R&D results should be used in modeling and decision support. This panel session will stimulate exchanges among a panel of PSA researchers, PSA analysts (“practitioners”), and PSA end-users, and with the audience. | |||||||||||||
| Speakers | |||||||||||||
|
|||||||||||||
